| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Added to standard fluorouracil and leucovorin therapy, irinotecan increases colorectal cancer survival with few adverse effects
|
Falcone, Alfredo
|
|
2001
|
2 |
2 |
p. 80-82
3 p.
|
article
|
| 2 |
Adding α -difluoromethylornithine to procarbazine, N -(2-chloroethyl)-N ′-cyclohexyl- N -nitrosurea and vincristine (PCV) chemotherapy has no benefit in postradiotherapy treatment of glioblastoma multiforme
|
Jakacki, Regina
|
|
2001
|
2 |
2 |
p. 89-90
2 p.
|
article
|
| 3 |
Adjuvant clodronate treatment does not reduce skeletal metastases and may reduce disease-free survival for node-positive breast cancer
|
Ejlertsen, Bent
|
|
2001
|
2 |
2 |
p. 96-97
2 p.
|
article
|
| 4 |
Amifostine is an effective radioprotector for people with head and neck cancer but has nausea and emesis side-effects
|
Kleinsasser, Norbert
|
|
2001
|
2 |
2 |
p. 107-108
2 p.
|
article
|
| 5 |
Anastrozole is just as effective and may have fewer side-effects than tamoxifen in first-line treatment of advanced postmenopausal breast cancer
|
Higa, Gerald M.
|
|
2001
|
2 |
2 |
p. 73-76
4 p.
|
article
|
| 6 |
Calcium supplements have no significant impact on colorectal adenoma recurrence, but fiber may increase recurrence risk
|
Martı́nez, Marı́a Elena
|
|
2001
|
2 |
2 |
p. 91-93
3 p.
|
article
|
| 7 |
Chemotherapy prior to loco-regional treatment has survival benefits for people with cancer of the oropharynx
|
Eckardt, André
|
|
2001
|
2 |
2 |
p. 109-110
2 p.
|
article
|
| 8 |
Combined chemotherapy and radiotherapy does not seem to reduce recurrence or improve survival compared to radiotherapy alone in people with non-small cell lung cancer
|
Westeel, Virginie
|
|
2001
|
2 |
2 |
p. 87-88
2 p.
|
article
|
| 9 |
Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer
|
Amadori, Dino
|
|
2001
|
2 |
2 |
p. 83-86
4 p.
|
article
|
| 10 |
EDITORIAL
|
|
|
2001
|
2 |
2 |
p. 61-
1 p.
|
article
|
| 11 |
Fluorouracil does not enhance the limited effectiveness of subcutaneous recombinant interleukin-2 and recombinant interferon alfa-2a for metastatic renal cancer
|
Figlin, R.A.
|
|
2001
|
2 |
2 |
p. 94-95
2 p.
|
article
|
| 12 |
Fruit and vegetable consumption does not protect against colon or rectal cancer
|
Cook, Nancy R.
|
|
2001
|
2 |
2 |
p. 64-65
2 p.
|
article
|
| 13 |
Glossary of terms
|
|
|
2001
|
2 |
2 |
p. 111-112
2 p.
|
article
|
| 14 |
Good inter-observer agreement for histological diagnosis of high-grade vulvar intraepithelial neoplasia using International Society for the Study of Vulvovaginal Diseases classification system
|
Sellors, John W.
|
|
2001
|
2 |
2 |
p. 66-67
2 p.
|
article
|
| 15 |
Granisetron is just as effective as ondansetron in the complete prevention of chemotherapy-induced nausea and vomiting
|
Domino, Karen B.
|
|
2001
|
2 |
2 |
p. 101-102
2 p.
|
article
|
| 16 |
High-dose chemotherapy and autologous bone marrow transplant have no benefit over standard chemotherapy for aggressive non-Hodgkin’s lymphoma
|
Ezzat, Adnan
|
|
2001
|
2 |
2 |
p. 98-100
3 p.
|
article
|
| 17 |
Individualized chemotherapy doses with granulocyte colony stimulating factor support have survival and toxicity benefits over marrow supported high dose chemotherapy
|
Rodenhuis, Sjoerd
|
|
2001
|
2 |
2 |
p. 77-79
3 p.
|
article
|
| 18 |
Morphological classification may help distinguish molecular subtypes of acute promyelocytic leukemia
|
Mattson, Joan C.
|
|
2001
|
2 |
2 |
p. 68-70
3 p.
|
article
|
| 19 |
Predisone has quality-of-life benefits over flutamide in the treatment of hormone-resistant prostate cancer
|
Adolfsson, Jan
|
|
2001
|
2 |
2 |
p. 103-104
2 p.
|
article
|
| 20 |
Serum concentrations of cancer antigen 125 may be an independent predictor of disease free and overall survival for women with primary fallopian tube carcinoma
|
Wong, Cheung
|
|
2001
|
2 |
2 |
p. 71-72
2 p.
|
article
|
| 21 |
Table A. Levels of evidence and grades of recommendations
|
|
|
2001
|
2 |
2 |
p. 113-
1 p.
|
article
|
| 22 |
Taming the NNT: representing results for busy clinicians
|
Muthu, Dr Vivek
|
|
2001
|
2 |
2 |
p. 62-63
2 p.
|
article
|
| 23 |
Whole brain radiotherapy used in addition to teniposide has a higher response rate for cerebral metastasis from small-cell lung cancer but no influence on survival rates compared to teniposide alone
|
Pirker, Robert
|
|
2001
|
2 |
2 |
p. 105-106
2 p.
|
article
|
Journal description